Literature DB >> 17052659

Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study.

Lisa F Barcellos1, Brinda B Kamdar, Patricia P Ramsay, Cari DeLoa, Robin R Lincoln, Stacy Caillier, Silke Schmidt, Jonathan L Haines, Margaret A Pericak-Vance, Jorge R Oksenberg, Stephen L Hauser.   

Abstract

BACKGROUND: Autoimmune mechanisms are thought to have a major role in the pathogenesis of multiple sclerosis. We aimed to identify coexisting autoimmune phenotypes in patients with multiple sclerosis from families with several members with the disease and in their first-degree relatives.
METHODS: A total of 176 families (386 individuals and 1107 first-degree relatives) were characterised for a history of other autoimmune disorders. Family-based or case-control analyses were done to assess the association of cytotoxic T-lymphocyte-antigen 4 (CTLA4) and protein tyrosine phosphatase (PTPN22) variants with susceptibility to multiple sclerosis.
FINDINGS: 46 (26%) index cases reported at least one coexisting autoimmune disorder. The most common were Hashimoto thyroiditis (10%), psoriasis (6%), inflammatory bowel disease (3%), and rheumatoid arthritis (2%). 112 (64%) families with a history of multiple sclerosis reported autoimmune disorders (excluding multiple sclerosis) in one or more first-degree relatives, whereas 64 (36%) families reported no history of autoimmunity. Similar to index cases, Hashimoto thyroiditis, psoriasis, and inflammatory bowel disease were also the most common disorders occurring in family members. A common variant within CTLA4 was strongly associated with multiple sclerosis in families who had other autoimmune diseases (p=0.009) but not in families without a history of other autoimmune disorders (p=0.90).
INTERPRETATION: The presence of various immune disorders in families with several members with multiple sclerosis suggests that the disease might arise on a background of a generalised susceptibility to autoimmunity. This distinct multiple-sclerosis phenotype, defined by its association with other autoimmune diseases, segregates with specific genotypes that could underlie the common susceptibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052659     DOI: 10.1016/S1474-4422(06)70552-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  61 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk?

Authors:  Idan Goren; Gad Segal; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2015-04-16       Impact factor: 2.980

3.  Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis.

Authors:  Si Chen; Chuiwen Deng; Chaojun Hu; Jing Li; Xiaoting Wen; Ziyan Wu; Yuan Li; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2015-08-29       Impact factor: 2.980

4.  Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.

Authors:  Ruth Ann Marrie; Ralph I Horwitz; Gary Cutter; Tuula Tyry; Timothy Vollmer
Journal:  Neuroepidemiology       Date:  2011-02-01       Impact factor: 3.282

5.  Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study.

Authors:  Arne Egesten; Lena Brandt; Tomas Olsson; Fredrik Granath; Malin Inghammar; Claes-Göran Löfdahl; Anders Ekbom
Journal:  Lung       Date:  2008-03-20       Impact factor: 2.584

Review 6.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

7.  Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study.

Authors:  Khalaf Kridin; Kyle Amber; Mogher Khamaisi; Doron Comaneshter; Erez Batat; Arnon D Cohen
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

8.  Multiple sclerosis: autoimmune associations in multiple sclerosis.

Authors:  Cris S Constantinescu; Bruno Gran
Journal:  Nat Rev Neurol       Date:  2010-11       Impact factor: 42.937

9.  The expanding genetic overlap between multiple sclerosis and type I diabetes.

Authors: 
Journal:  Genes Immun       Date:  2008-11-06       Impact factor: 2.676

10.  IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Authors:  Antonio Alcina; María Fedetz; Dorothy Ndagire; Oscar Fernández; Laura Leyva; Miguel Guerrero; María M Abad-Grau; Carmen Arnal; Concepción Delgado; Miguel Lucas; Guillermo Izquierdo; Fuencisla Matesanz
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.